Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Herdrich

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular & General Genetics : MGG|January 1, 1981
Misrepair mutagenesis in Myxococcus xanthus: induction of rifampicin-resistant mutants by N-methyl-N'-nitro-N-nitrosoguanidine and ultraviolet-irradiationK Herdrich, K Grimm
Cancer Treatment Reviews|September 1, 1983
Ifosfamide--current aspects and perspectivesP Hilgard, K Herdrich, W Brade
Cancer Chemotherapy and Pharmacology|January 1, 1986
Comparative activity of ifosfamide and cyclophosphamideW Brade, S Seeber, K Herdrich
Cancer Treatment Reviews|March 1, 1985
Ifosfamide--pharmacology, safety and therapeutic potentialW P Brade, K Herdrich, M Varini
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Dosing and side-effects of ifosfamide plus mesnaW P Brade, K Herdrich, U Kachel-Fischer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular & General Genetics : MGG|January 1, 1981
Misrepair mutagenesis in Myxococcus xanthus: induction of rifampicin-resistant mutants by N-methyl-N'-nitro-N-nitrosoguanidine and ultraviolet-irradiationK Herdrich, K Grimm
Cancer Treatment Reviews|September 1, 1983
Ifosfamide--current aspects and perspectivesP Hilgard, K Herdrich, W Brade
Cancer Chemotherapy and Pharmacology|January 1, 1986
Comparative activity of ifosfamide and cyclophosphamideW Brade, S Seeber, K Herdrich
Cancer Treatment Reviews|March 1, 1985
Ifosfamide--pharmacology, safety and therapeutic potentialW P Brade, K Herdrich, M Varini
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Dosing and side-effects of ifosfamide plus mesnaW P Brade, K Herdrich, U Kachel-Fischer, et al.
Pageof 1